Seizing opportunities > in new markets
Asia is an important growth market for Fresenius Medical Care. Approximately 620,000 patients with chronic kidney failure are currently being treated in this region, and every year this number increases by about 10 to 11%. We will continue to take advantage of this growth potential. The significant demand for dialysis services offers substantial opportunities to expand our network of clinics in the Asian countries.
In 2008, Fresenius Medical Care achieved sales of US$ 606 million in the Asia-Pacific region. Our goal is to continue our strong organic growth and to increase sales to more than US$ 800 million in constant currency by 2010.
| FRESENIUS MEDICAL CARE IN ASIA |
|||
| 2008 | 2007 | Change | |
| Sales (in million US$) | 606 | 541 | 12% |
| Employees (December 31) | 3,558 | 3,095 | 15% |
| Dialysis patients (December 31) | 9,158 | 7,789 | 18% |
| Dialysis treatments (million) | 1.34 | 1.21 | 11% |
| Dialysis clinics (December 31) | 125 | 105 | 19% |